FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:1628-1629 November 26, 1998 Number 22 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Rubinstein, P. PubMed Citation

During the past decade the use of placental blood as a source of transplantable hematopoietic stem cells has been accelerating. Initially, the placental blood was obtained from siblings, but now recipients of transplants from unrelated donors (allogeneic transplants) account for almost all patients who receive transplants of hematopoietic stem cells from placental blood.^1,2,3 In this issue of the Journal, Rubinstein and his colleagues report the results of 562 allogeneic transplantations of hematopoietic stem cells in placental-blood units stored at the New York Blood Center.⁴ Their overall results confirm the conclusions that others have reached: reproducible stem-cell engraftment can be achieved . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Suarez, A., Mozo, L., Gutierrez, C. (2002). Generation of CD4+CD45RA+ Effector T Cells by Stimulation in the Presence of Cyclic Adenosine 5'-Monophosphate- Elevating Agents. J. Immunol. 169: 1159-1167 [Abstract] [Full Text]  
• Siena, S., Schiavo, R., Pedrazzoli, P., Carlo-Stella, C. (2000). Therapeutic Relevance of CD34 Cell Dose in Blood Cell Transplantation for Cancer Therapy. JCO 18: 1360-1377 [Abstract] [Full Text]  
• Annas, G. J. (1999). Waste and Longing -- The Legal Status of Placental-Blood Banking. NEJM 340: 1521-1524 [Full Text]